SpaceX IPO: Here's How to Buy SPCX Stock Right Now

SpaceX debuted at $135 per share, implying a $1.77 trillion valuation and making it the largest IPO in history. The article argues the stock is richly valued at nearly 100 times sales and cites Morningstar's fair value estimate of about $780 billion, less than half the IPO valuation. It notes retail investors can now buy SPCX on the open market, but warns debut-day volatility could be significant.

Analysis

The immediate winner is not the issuer so much as the distribution stack: the brokers that earned allocation rights and the platforms that can monetize order flow during the first 1-3 sessions. A retail-heavy float on day one usually creates an unstable price path because the marginal holder is momentum-sensitive and less anchored on intrinsic value, which increases the odds of both an opening squeeze and a sharp retracement once first-day novelty fades. That setup also benefits volatility sellers only after the first few hours; before then, they are exposed to gap risk.

The real second-order effect is competitive capital rotation. A mega-cap IPO at a stretched multiple tends to siphon incremental risk appetite away from adjacent growth franchises with cleaner paths to earnings compounding, especially the large platform and semiconductor names in the same “innovation premium” bucket. In practice, that can pressure sentiment for the next several weeks even if fundamentals elsewhere are unchanged, because investors benchmark new money against the headline valuation anchor rather than against sector cash flow yields.

The contrarian point the market may be missing is that “great business” and “good IPO” are not the same trade. When a company comes public already priced for perfection, the forward return profile is dominated by execution slippage, lock-up overhang, and any deceleration in the narrative engine; those risks matter more over the next 3-12 months than the long-term addressable market. If secondary supply and insider monetization arrive into a crowded ownership base, the stock can underperform despite continued operational strength.

For the named tickers, the most interesting signal is that the article is more sentiment-negative for the valuation-comparison names than for the business itself. Morningstar-style fair-value framing can become a short-term catalyst for mean reversion if early trading confirms an extreme premium, while broker-related names may see a modest flow bump from client engagement without any real earnings delta. The setup argues for trading the overhang, not the story.

Key Decisions for Investors

• Fade the debut pop: initiate a tactical short or buy put spreads on SPCX after the first 1-2 volatile sessions, targeting a 10-20% retracement over 2-6 weeks; cover quickly if volume stays >2x average and price holds above the opening range.
• Pair trade: long NVDA / short SPCX on a 1-3 month horizon, expressing preference for a proven cash-flow compounder versus a newly priced narrative multiple; risk is continued benchmark-driven momentum in SPCX, so keep the short leg sized smaller than the long.
• Buy SCHW and SOFI on any post-IPO pullback if retail activity remains elevated for several sessions; the asymmetric upside is incremental engagement and funded-account activity, while downside is limited if the IPO excitement fades.
• Avoid fresh long exposure to MORN into the next 1-4 weeks; the article’s valuation anchor and fair-value comparison can create a sentiment headwind for research/ratings franchises if investors become more price-sensitive to premium assets.
• If willing to express a pure volatility view, wait for implied vol to stabilize and sell SPCX strangles only after day-3 price discovery; early premium is likely rich, but entering too soon carries unacceptable gap risk.